Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

The treatment allows patients to have a steady flow of dopamine that is needed to cope with the tremors, stiffness and slow movement that often comes with Parkinson’s disease.

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

"For too long, the Parkinson's community has had limited treatment options for advanced disease. Due to the progressive nature of the disease, oral medications are eventually no longer as ...

your disease will go slower than if you did not, 100%," said Dr. Ihtsham Haq, a Parkinson's expert at the University of Miami's Miller School of Medicine and works with the Parkinson's Foundation.

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...

and their applications to disorders like Parkinson' disease. Dr. Madhavan practiced clinical medicine, but moved to research, as she felt that advances in basic science are the best way to treat ...

Parkinson’s disease (PD ... it can take decades for the disease to progress to advanced stages. Scientists have studied various medications over the past 30 years to try to slow down or block ...

Veterans were included if they had Parkinson’s disease based on ≥ 1 ICD code and confirmed by symptoms and medication for Parkinson’s disease documented in the electronic medical record (EMR).